Cellectis (CLLS) Short Interest Ratio & Short Volume $1.87 -0.04 (-2.09%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Cellectis Short Interest DataCellectis (CLLS) has a short interest of 156,200 shares. This marks a -54.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 50,154 shares to cover all short positions.Current Short Interest156,200 sharesPrevious Short Interest346,800 sharesChange Vs. Previous Month-54.96%Dollar Volume Sold Short$278,036.00Short Interest Ratio3.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares55,580,000 sharesPercentage of Shares Shorted0.28%Today's Trading Volume72,315 sharesAverage Trading Volume50,154 sharesToday's Volume Vs. Average144% Short Selling Cellectis? Sign up to receive the latest short interest report for Cellectis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLLS Short Interest Over TimeCLLS Days to Cover Over TimeCLLS Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Cellectis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024156,200 shares $278,036.00 -55.0%N/A3.6 $1.78 10/15/2024346,800 shares $658,920.00 -2.6%N/A7.6 $1.90 9/30/2024356,100 shares $762,054.00 -2.1%N/A8.5 $2.14 9/15/2024363,600 shares $818,100.00 -4.9%N/A8.4 $2.25 8/31/2024382,400 shares $917,760.00 -3.3%N/A7.1 $2.40 8/15/2024395,400 shares $806,616.00 -10.3%N/A7.4 $2.04 Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024440,700 shares $973,947.00 -0.5%N/A8 $2.21 7/15/2024443,100 shares $926,079.00 +1.4%N/A8.1 $2.09 6/30/2024436,800 shares $816,816.00 +4.5%N/A7.8 $1.87 6/15/2024418,200 shares $940,950.00 -1.4%N/A7.5 $2.25 5/31/2024424,200 shares $1.15 million -16.8%N/A9.1 $2.71 5/15/2024509,900 shares $1.57 million -22.3%N/A9.9 $3.08 4/30/2024656,100 shares $1.68 million -2.5%N/A12.9 $2.56 4/15/2024672,800 shares $1.76 million -0.6%N/A17.8 $2.62 3/31/2024676,500 shares $1.79 million -0.4%N/A16.3 $2.65 3/15/2024679,300 shares $1.73 million -6.6%N/A13.5 $2.54 2/29/2024727,500 shares $1.88 million -0.1%N/A10.6 $2.58 2/15/2024728,200 shares $2.08 million -0.9%N/A8.2 $2.85 1/31/2024735,100 shares $2.21 million -4.2%N/A3.6 $3.00 1/15/2024767,300 shares $2.22 million -1.9%N/A0.4 $2.89 12/31/2023781,800 shares $2.41 million -7.0%N/A0.4 $3.08 12/15/2023840,900 shares $2.69 million -19.9%N/A0.5 $3.20 11/30/20231,050,000 shares $3.13 million -28.1%N/A0.6 $2.98 11/15/20231,460,000 shares $4.09 million +302.8%N/A0.8 $2.80 10/31/2023362,500 shares $349,450.00 -2.7%N/A0.2 $0.96 10/15/2023372,400 shares $513,912.00 +7.9%N/A6.9 $1.38 9/30/2023345,200 shares $545,416.00 +7.6%N/A5.6 $1.58 9/15/2023320,800 shares $545,360.00 -0.5%N/A6.3 $1.70 8/31/2023322,300 shares $667,161.00 -2.7%N/A6.5 $2.07 8/15/2023331,100 shares $652,267.00 -3.5%N/A6.5 $1.97 7/31/2023343,200 shares $734,448.00 +9.2%N/A5.7 $2.14 7/15/2023314,400 shares $704,287.44 +0.5%N/A5.5 $2.24 6/30/2023312,800 shares $615,434.00 -1.4%N/A6.2 $1.97 6/15/2023317,300 shares $640,946.00 +2.6%N/A5.2 $2.02 5/31/2023309,200 shares $587,480.00 -2.5%N/A4.5 $1.90 5/15/2023317,200 shares $558,272.00 +0.2%N/A4.6 $1.76 4/30/2023316,700 shares $595,396.00 -13.0%N/A3.7 $1.88 4/15/2023363,800 shares $742,152.00 -0.2%N/A3.2 $2.04 3/31/2023364,600 shares $703,678.00 -2.3%N/A2.8 $1.93 3/15/2023373,100 shares $682,773.00 +1.4%N/A2.7 $1.83Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 2/28/2023367,900 shares $813,059.00 -6.6%N/A2.5 $2.21 2/15/2023393,800 shares $945,120.00 +5.4%N/A2.6 $2.40 1/31/2023373,600 shares $1.14 million +34.6%N/A2.4 $3.05 1/15/2023277,600 shares $1.07 million +31.0%0.6%2.4 $3.84 12/30/2022211,900 shares $444,990.00 -32.2%0.5%1.9 $2.10 12/15/2022312,400 shares $702,900.00 -17.4%0.7%3.2 $2.25 11/30/2022378,000 shares $831,600.00 -28.2%0.8%4.5 $2.20 11/15/2022526,300 shares $1.18 million -9.3%1.2%6.3 $2.25 10/31/2022580,400 shares $1.44 million -13.9%1.3%6.9 $2.49 10/15/2022674,400 shares $1.66 million -6.7%1.5%6.5 $2.46 9/30/2022722,600 shares $1.65 million -11.8%1.6%6.6 $2.29 9/15/2022819,400 shares $2.61 million -2.4%1.8%7.2 $3.19 8/31/2022839,700 shares $2.78 million -2.4%1.9%6.5 $3.31 8/15/2022860,300 shares $3.51 million -3.0%1.9%6.3 $4.08 7/31/2022887,300 shares $2.32 million -9.2%2.0%6.1 $2.62 7/15/2022976,800 shares $2.40 million +1.0%2.2%6.7 $2.46 6/30/2022966,900 shares $2.74 million -4.3%2.2%6.7 $2.83 6/15/20221,010,000 shares $2.53 million -2.9%2.2%6.7 $2.50 5/31/20221,040,000 shares $3.76 million -1.9%2.3%5.2 $3.62 5/15/20221,060,000 shares $3.36 million -12.4%2.4%4.4 $3.17 4/30/20221,210,000 shares $4.24 million -24.8%2.7%4.7 $3.50 4/15/20221,610,000 shares $6.65 million -5.9%3.6%5.8 $4.13 3/31/20221,710,000 shares $7.76 million -4.5%3.8%5.5 $4.54 3/15/20221,790,000 shares $7.59 million -8.2%4.0%5.8 $4.24 2/28/20221,950,000 shares $8.83 million +18.9%4.3%6.5 $4.53 2/15/20221,640,000 shares $9.18 million +46.4%3.6%6.4 $5.60 1/31/20221,120,000 shares $6.96 million +16.7%2.5%4.6 $6.21 1/15/2022959,700 shares $7.00 million +31.4%N/A4.4 $7.29 12/31/2021730,200 shares $5.93 million +9.4%1.6%3.3 $8.12 12/15/2021667,300 shares $5.61 million -7.7%1.5%2.9 $8.41 11/30/2021722,900 shares $6.23 million +17.9%1.6%3.4 $8.62 11/15/2021613,200 shares $6.12 million +2.6%1.4%3.1 $9.98 10/29/2021597,800 shares $6.43 million -38.0%1.3%3 $10.76 10/15/2021964,500 shares $10.45 million -22.8%2.1%4.9 $10.83 9/30/20211,250,000 shares $15.76 million -1.6%2.8%6.7 $12.61 9/15/20211,270,000 shares $17.78 million +1.6%2.8%7.6 $14.00 8/31/20211,250,000 shares $17.98 million -3.9%2.8%6.7 $14.38 8/13/20211,300,000 shares $16.28 million -7.8%2.9%6.2 $12.52 7/30/20211,410,000 shares $18.26 million No Change3.1%6.5 $12.95 7/15/20211,410,000 shares $19.29 million +11.9%3.1%6.4 $13.68 6/30/20211,260,000 shares $19.49 million +5.9%2.8%5.6 $15.47 6/15/20211,190,000 shares $17.92 million -21.7%2.6%4.5 $15.06 5/28/20211,520,000 shares $23.82 million +2.7%3.4%5.4 $15.67 5/14/20211,480,000 shares $21.93 million +28.7%N/A4.5 $14.82 4/30/20211,150,000 shares $21.76 million -0.9%2.8%3.2 $18.92 4/15/20211,160,000 shares $22.63 million -5.7%2.8%2.9 $19.51 3/31/20211,230,000 shares $23.14 million +10.8%3.2%2.7 $18.81 3/15/20211,110,000 shares $22.14 million +28.1%2.9%2.4 $19.95 2/26/2021866,800 shares $17.89 million +117.8%2.2%1.7 $20.64 2/12/2021398,000 shares $10.70 million -9.3%1.0%0.9 $26.88Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 1/29/2021438,700 shares $12.39 million -28.6%1.0%1 $28.25 1/15/2021614,200 shares $19.00 million -21.5%1.5%1.7 $30.94 12/31/2020782,100 shares $23.00 million -10.9%1.9%2.3 $29.41 12/15/2020878,100 shares $27.41 million -3.6%2.1%3.1 $31.21 11/30/2020911,200 shares $22.06 million -10.7%2.2%4.6 $24.21 11/15/20201,020,000 shares $19.50 million +20.8%2.4%5.8 $19.12 10/30/2020844,700 shares $13.82 million +16.8%2.0%4.9 $16.36 10/15/2020723,400 shares $15.86 million +28.2%1.7%4.5 $21.92 9/30/2020564,200 shares $10.44 million -0.5%1.3%3.7 $18.50 9/15/2020567,100 shares $11.44 million +4.8%1.3%3.7 $20.18 8/31/2020540,900 shares $9.98 million +18.4%1.3%3.2 $18.45 8/14/2020456,800 shares $7.82 million +32.1%1.1%2.4 $17.12 7/31/2020345,700 shares $5.43 million -0.1%0.8%1.6 $15.70 7/15/2020345,900 shares $6.15 million -3.7%0.8%1.6 $17.77 6/30/2020359,300 shares $6.45 million +39.9%0.9%1.7 $17.94 6/15/2020256,900 shares $4.20 million -16.9%0.6%1.2 $16.34 5/29/2020309,200 shares $5.71 million -8.0%0.7%1.6 $18.47 5/15/2020336,000 shares $6.49 million -5.8%0.8%1.9 $19.32 4/30/2020356,700 shares $4.65 million +34.4%0.8%2.4 $13.05 4/15/2020265,400 shares $2.89 million +21.2%0.6%1.8 $10.89 3/31/2020218,900 shares $2.64 million -35.3%0.5%1.6 $12.06 3/13/2020338,500 shares $3.28 million +5.7%0.8%2.6 $9.70 2/28/2020320,200 shares $2.50 million +13.0%0.8%2.3 $7.81 2/14/2020283,300 shares $3.52 million +8.2%0.7%2.2 $12.42 1/31/2020261,800 shares $4.38 million +15.4%0.6%2 $16.74 1/15/2020226,800 shares $4.02 million -7.5%0.5%1.7 $17.71 12/31/2019245,100 shares $4.02 million -22.7%0.6%2 $16.39 CLLS Short Interest - Frequently Asked Questions What is Cellectis' current short interest? Short interest is the volume of Cellectis shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 156,200 shares of CLLS short. Learn More on Cellectis' current short interest. What is a good short interest ratio for Cellectis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLLS shares currently have a short interest ratio of 4.0. Learn More on Cellectis's short interest ratio. Is Cellectis' short interest increasing or decreasing? Cellectis saw a decline in short interest in October. As of October 31st, there was short interest totaling 156,200 shares, a decline of 55.0% from the previous total of 346,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cellectis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cellectis: MeiraGTx Holdings plc (2.56%), Amylyx Pharmaceuticals, Inc. (3.13%), Akebia Therapeutics, Inc. (6.80%), 4D Molecular Therapeutics, Inc. (15.74%), Cryoport, Inc. (6.10%), Design Therapeutics, Inc. (8.07%), Valneva SE (0.06%), C4 Therapeutics, Inc. (8.29%), Alvotech (0.07%), Voyager Therapeutics, Inc. (5.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Cellectis stock? Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. CLLS shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectis? A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further. How often is Cellectis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MeiraGTx Short Interest Amylyx Pharmaceuticals Short Interest Akebia Therapeutics Short Interest 4D Molecular Therapeutics Short Interest Cryoport Short Interest Design Therapeutics Short Interest Valneva Short Interest C4 Therapeutics Short Interest Alvotech Short Interest Voyager Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLLS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
